ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
Ageing and Diabetes mellitus are two well-known risk factors for cardiovascular disease (CVD). Ageing alone is associated with decline in physiological function leading to chronic diseases, such as diabetes mellitus, CVD, cognitive impairment, and physical disability. Diabetes mellitus is a recognized cause of accelerated aging, and there is evidence that aging and diabetes mellitus share common pathophysiological pathways. The mechanisms linking advancing age to metabolic dysregulation, are multifactorial and complex. Furthermore the management of older adults with diabetes is clearly more complicated, given the observation that they commonly have multiple coexisting medical conditions that can impact clinical management. The heterogeneity in the health status of older adults with frailty and multiple comorbid conditions and the paucity of evidence from clinical trials, represent another point of scientific discussion and future potential research. Under these circumstances the establishment of the best practice protocols and the implementation of the up-to-date evidence-based individualized therapeutic regimens, in order to control diabetes, aiming simultaneously at the aging process, still remains a real challenge, in every day’s clinical practice, in order to warrant the best outcomes.
Georgios Mitrou is an experienced Managing Director PhD, with a demonstrated history of working in the hospital & health care industry. Skilled in Diabetes, Clinical Research, Medical Education, Hypertension, and Medicine. Strong research professional focused in Internal Medicine, Geriatrics and Gerontology, Longevity and Anti-Aging Medicine.